Clinical trial
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer
NCT05364645
Study timeline
Study start (estimated)2022-07-25Date precision: day
Registry last updated2024-07-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Non-Small Cell Carcinomaunresolved
Recurrent Lung Non-Small Cell Carcinomaunresolved
Stage IV Lung Cancer AJCC v8unresolved
Stage IVA Lung Cancer AJCC v8unresolved
Stage IVB Lung Cancer AJCC v8unresolved
Interventions
CarboplatinDRUG · verified · RxNorm: carboplatin
PemetrexedDRUG · verified · RxNorm: pemetrexed
SelpercatinibDRUG · verified · RxNorm: selpercatinib
Sponsors & collaborators
SWOG Cancer Research Networklead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
PittsburghPennsylvania, United States5GreenvilleSouth Carolina, United States4FlintMichigan, United States4MilwaukeeWisconsin, United States3SpringfieldIllinois, United States3FargoNorth Dakota, United States3ChicagoIllinois, United States2Los AngelesCalifornia, United States2San FranciscoCalifornia, United States2ClevelandOhio, United States2Las VegasNevada, United States2CharlestonSouth Carolina, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05364645 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.